InsidersTradesSigma
Follow the 삼진제약 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 삼진제약 has logged 2 public disclosures. Market capitalisation: €222.9bn. The latest transaction was reported on 2 June 2026 (Other). Among the most active insiders: 최승주. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Samjin Pharmaceutical is a South Korean pharmaceutical company focused on the research, development, and manufacturing of medications. It is listed on the XKRX market.